Form 4: Baxter International EVP, Chief HR Officer Jeanne K. Mason Reports Stock Transactions
SEC Form 4 Filing
Jeanne K. Mason, EVP and Chief HR Officer of Baxter International, reports the acquisition and disposal of company stock and stock options on March 6, 2025.
Summary
- On March 6, 2025, Jeanne K. Mason, EVP and Chief HR Officer of Baxter International, reported transactions involving the company's stock.
- Mason forfeited 4,375 shares to cover tax withholdings related to the settlement of vested restricted stock units at a price of $35.44.
- She also received a grant of 15,696 restricted stock units, which will vest in three equal annual installments starting on March 6, 2026.
- Additionally, Mason acquired 52,331 stock options with an exercise price of $35.44, which become exercisable in three equal annual installments beginning on March 6, 2026.
- Following these transactions, Mason directly owns 199,659 shares of Baxter International stock and 52,331 stock options.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The transactions are part of a standard compensation package, indicating alignment between the executive and the company's long-term performance. There are no red flags or negative implications.
Positives
- The grant of restricted stock units and stock options to a key executive suggests a continued alignment of interests between management and shareholders.
Future Outlook
The restricted stock units and stock options vest over time, incentivizing the executive to contribute to the company's long-term success.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company executives and their confidence in the company's future prospects.
Comparison to Industry Standards
- Executive compensation packages, including stock options and restricted stock units, are common in publicly traded companies like Baxter International to align management's interests with those of shareholders.
- The vesting schedules for the restricted stock units and stock options are typical, usually spanning several years to incentivize long-term performance.
- Comparable companies such as Medtronic, Johnson & Johnson, and Abbott Laboratories also utilize similar equity-based compensation strategies for their executives.
Stakeholder Impact
- The transactions have a minor positive impact on shareholders by aligning executive interests with long-term company performance.
Key Dates
| Date | Description |
|---|---|
| 03/06/2024 | Date of the grant of restricted stock units that vested on March 6, 2025. |
| 03/06/2025 | Date of the reported transactions, including stock forfeiture, grant of restricted stock units, and acquisition of stock options. |
| 03/06/2026 | First vesting date for the restricted stock units and first exercisable date for the stock options, both in three equal annual installments. |
| 03/06/2035 | Expiration date of the acquired stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.